Where is the live CopyMark page for USPTO serial 99529874?

The live record is at https://getcopymark.com/trademark/99529874. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns CELLSEXPRESS?

According to the public USPTO record for serial number 99529874, the listed owner(s) include: StemExpress, LLC.

What is USPTO serial number 99529874?

Serial number 99529874 is the USPTO application identifier for the mark CELLSEXPRESS. It is used to track examination, publication, and registration of this trademark.

Which trademark classes cover CELLSEXPRESS?

The public record lists International Classes: 001. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: CELLSEXPRESS Serial# 99529874 | status 681; last event CNSA | Trademark Info & Attorney Guidance

Q: What is the current status of CELLSEXPRESS?

CELLSEXPRESS (99529874) currently shows USPTO status code 681 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CELLSEXPRESS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

StemExpress, LLC
Folsom, CA, US
Other trademarks owned by StemExpress, LLC

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kaitlyn Saberin

Kaitlyn Saberin Folsom Jackson O'Malley LLP500 Capitol Mall Ste 1550Sacramento, CA 95814United States

Goods and services

Class	Description	Status	First use
001	Biological tissue, namely, blood, isolated cells, stem cells, umbilical cords, umbilical cord blood, GMP blood products in the nature of blood, isolated cells, stem cells and bone marrow for use in scientific and medical research	ACTIVE	Jul 31, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Oct 13, 2026	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Oct 8, 2026	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Oct 8, 2026	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Oct 8, 2026	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 10, 2026	XELG	APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED	—
Jul 10, 2026	XELR	APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED	—
Apr 10, 2026	GNRN	NOTIFICATION OF NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 10, 2026	GNRT	NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 10, 2026	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 8, 2026	DOCK	ASSIGNED TO EXAMINER	—
Feb 12, 2026	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Dec 4, 2025	MAFR	APPLICATION FILING RECEIPT MAILED	—
Dec 4, 2025	NWAP	NEW APPLICATION ENTERED	—

CELLSEXPRESS